Canada Markets open in 7 hrs

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.24+0.09 (+0.59%)
At close: 04:00PM EST
14.70 -0.54 (-3.54%)
After hours: 05:20PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 320.88
52 Week Low 36.51
50-Day Moving Average 316.58
200-Day Moving Average 313.43

Share Statistics

Avg Vol (3 month) 3648.15k
Avg Vol (10 day) 3555.52k
Shares Outstanding 558.48M
Implied Shares Outstanding 6N/A
Float 836.69M
% Held by Insiders 127.64%
% Held by Institutions 174.37%
Shares Short (Oct 13, 2022) 47.38M
Short Ratio (Oct 13, 2022) 49.41
Short % of Float (Oct 13, 2022) 417.02%
Short % of Shares Outstanding (Oct 13, 2022) 411.05%
Shares Short (prior month Sept 14, 2022) 47.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin -236.57%
Operating Margin (ttm)-213.08%

Management Effectiveness

Return on Assets (ttm)-27.75%
Return on Equity (ttm)-60.63%

Income Statement

Revenue (ttm)109.14M
Revenue Per Share (ttm)1.72
Quarterly Revenue Growth (yoy)37.80%
Gross Profit (ttm)-141.62M
EBITDA -229.41M
Net Income Avi to Common (ttm)-258.19M
Diluted EPS (ttm)-4.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)383.85M
Total Cash Per Share (mrq)5.74
Total Debt (mrq)30.58M
Total Debt/Equity (mrq)7.55
Current Ratio (mrq)6.02
Book Value Per Share (mrq)9.44

Cash Flow Statement

Operating Cash Flow (ttm)-218.05M
Levered Free Cash Flow (ttm)-112.45M